Storia in 2 fonti

CordenPharma Acquires AmbioPharm to Expand Global Peptide API Capacity

Raccontata da

morningstar.com

fiercepharma.com

Confronto fonti

2 prospettive sulla stessa storia

AI · summaries

morningstar.comStai leggendo11 h fa

CordenPharma Acquires AmbioPharm to Expand Global Peptide API Capacity

originale

fiercepharma.com1 h fa

GLP-1 manufacturer CordenPharma strikes deal for peptide CDMO, lining up new production sites in US and China

Amid a nearly $1 billion GLP-1 manufacturing expansion that began in 2024, CMDO CordenPharma is doubling down on its peptide capacity ambitions. | Amid a nearly $1 billion GLP-1 manufacturing expansion that began in…

Leggi questa versione → originale

Timeline cronologica

mercoledì 27 maggio 2026·morningstar.com
CordenPharma Acquires AmbioPharm to Expand Global Peptide API Capacity
CordenPharma Acquires AmbioPharm to Expand Global Peptide API Capacity
mercoledì 27 maggio 2026·fiercepharma.com
GLP-1 manufacturer CordenPharma strikes deal for peptide CDMO, lining up new production sites in US and China
Amid a nearly $1 billion GLP-1 manufacturing expansion that began in 2024, CMDO CordenPharma is doubling down on its peptide capacity ambitions. | Amid a nearly $1 billion GLP-1…